Metabolic Syndrome in Childhood from Impaired Carbohydrate Metabolism to Nonalcoholic Fatty Liver Disease

REFERENCES

• TargherGDayCPBonoraE: Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363: 1341– 1350, 2010.
   PubMed Web of Science ®Google Scholar
• GhouriNPreissDSattarN: Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology 52: 1156– 1161, 2010.
   PubMed Web of Science ®Google Scholar
• MancoMMarcelliniMDevitoRComparcolaDSartorelliMRNobiliV: Metabolic syndrome and liver histology in pediatric non-alcoholic steatohepatitis. Int J Obes (Lond) 32: 381– 387, 2008.
   PubMed Web of Science ®Google Scholar
• MancoMPutignaniLBottazzoGF: Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 31: 817– 844, 2010.
   PubMed Web of Science ®Google Scholar
• FabbriniESullivanSKleinS: Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51: 679– 689, 2010.
   PubMed Web of Science ®Google Scholar
• GreggEW: Are children the future of type 2 diabetes prevention? N Engl J Med 362: 548– 550, 2010.
   PubMed Web of Science ®Google Scholar
• MagnussenCGKoskinenJChenWThomsonRSchmidtMDSrinivasanSRKivimäkiMMattssonNKähönenMLaitinenTTaittonenLRönnemaaTViikariJSBerensonGSJuonalaMRaitakariOT: Pediatric metabolic syndrome predicts adulthood metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus but is no better than body mass index alone: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study. Circulation 122: 1604– 1611, 2010.
   PubMed Web of Science ®Google Scholar
• ReinehrTde SousaGToschkeAMAndlerW: Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach. Arch Dis Child 92: 1067– 1072, 2007
   PubMed Web of Science ®Google Scholar
• American Heart Association: Statistical Fact Sheet—Risk Factors 2008 Update. Accessed at: http://www.americanheart.org/downloadable/heart/1197995069526FS15META08.pdf (Updated October 25, 2010.)
   Google Scholar
• AnguloP: Nonalcoholic fatty liver disease. N Engl J Med 346: 1221– 1231, 2002.
   PubMed Web of Science ®Google Scholar
• SchwimmerJBDeutschRKahenTLavineJEStanleyCBehlingC: Prevalence of fatty liver in children and adolescents. Pediatrics 118: 1388– 1393, 2006.
   PubMed Web of Science ®Google Scholar
• FraserALongneckerMPLawlorDA: Prevalence of elevated alanine aminotransferase among U.S. adolescents and associated factors: NHANES 1999–2004. Gastroenterology 133: 1814– 1820, 2007.
   PubMed Web of Science ®Google Scholar
• WiegandSKellerKMRöblML'AllemandDReinehrTWidhalmKHollRW the APV-Study Group, the German Competence Network Adipositas: Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16,390 overweight or obese children and adolescents. Int J Obes (Lond) 34: 1468– 1474, 2010.
   PubMed Web of Science ®Google Scholar
• MancoMBedogniGMarcelliniMDevitoRCiampaliniPSartorelliMRComparcolaDPiemonteFNobiliV: Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. Gut 57: 1283– 1287, 2008.
   PubMed Web of Science ®Google Scholar
• MancoMBottazzoGDeVitoRMarcelliniMMingroneGNobiliV: Nonalcoholic fatty liver disease in children. J Am Coll Nutr 27: 667– 676, 2008.
   PubMed Web of Science ®Google Scholar
• SanyalAJ: AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123: 1705– 1725, 2002.
   PubMedGoogle Scholar
• MancoMAlisiANobiliV: Risk of severe liver disease in NAFLD with normal ALT levels: a pediatric report. Hepatology 48: 2087– 2088, 2008.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association: Type 2 diabetes in children and adolescents. Diabetes Care 23: 381– 389, 2000.
   PubMed Web of Science ®Google Scholar
• SinhaRFischGTeagueBTamborlaneWVBanyasBAllenKSavoyeMRiegerVTaksaliSBarbettaGSherwinRSCaprioS: Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346: 802– 810, 2002.
   PubMed Web of Science ®Google Scholar
• WiegandSMaikowskiUBlankensteinOBiebermannHTarnowPGrütersA: Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity—a problem that is no longer restricted to minority groups. Eur J Endocrinol 151: 199– 206, 2004.
   PubMed Web of Science ®Google Scholar
• CambuliVMIncaniMPiliaSCongiuTCavalloMGCossuESentinelliFMariottiSLocheSBaroniMG: Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes. Diabetes Metab Res Rev 25: 528– 534, 2009.
   PubMed Web of Science ®Google Scholar
• MaffeisCPinelliLBrambillaPBanzatoCValzolgherLUlmiDDi CandiaSCammarataBMorandiA: Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents. Obesity 18: 1437– 1442, 2010.
   PubMed Web of Science ®Google Scholar
• O'MalleyGSantoroNNorthrupVD'AdamoEShawMEldrichSCaprioS: High normal fasting glucose level in obese youth: a marker for insulin resistance and beta cell dysregulation. Diabetologia 53: 1199– 1209, 2010.
   PubMed Web of Science ®Google Scholar
• FerranniniE: The stunned beta cell: a brief history. Cell Metab 11: 349– 352, 2010.
   PubMed Web of Science ®Google Scholar
• MancoMCalvaniMMingroneG: Effects of dietary fatty acids on insulin sensitivity and secretion. Diabetes Obes Metab 6: 402– 413, 2004.
   PubMed Web of Science ®Google Scholar
• CaniPDAmarJIglesiasMAPoggiMKnaufCBastelicaDNeyrinckAMFavaFTuohyKMChaboCWagetADelméeECousinBSulpiceTChamontinBFerrièresJTantiJFGibsonGRCasteillaLDelzenneNMAlessiMCBurcelinR: Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761– 1772, 2007.
   PubMed Web of Science ®Google Scholar
• SchwimmerJBPardeePELavineJEBlumkinAKCookS: Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 118: 277– 283, 2008.
   PubMed Web of Science ®Google Scholar
• PattonHMLavineJEVan NattaMLSchwimmerJBKleinerDMollestonJ Nonalcoholic Steatohepatitis Clinical Research Network: Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. Gastroenterology 135: 1961– 1971, 2008.
   PubMed Web of Science ®Google Scholar
• KleinerDEBruntEMVan NattaMBehlingCContosMJCummingsOWFerrellLDLiuYCTorbensonMSUnalp-AridaAYehMMcCulloughAJSanyalAJ Nonalcoholic Steatohepatitis Clinical Research Network: Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313– 1321, 2005.
   PubMed Web of Science ®Google Scholar
• NobiliVAlkhouriNAlisiAOttinoSLopezRMancoMFeldsteinAE: Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 7: 575– 579, 2009.
   PubMed Web of Science ®Google Scholar
• MancoMMarcelliniMGiannoneGNobiliV: Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease. Am J Clin Pathol 127: 954– 960, 2007.
   PubMed Web of Science ®Google Scholar
• NobiliVMancoMCiampaliniPDiciommoVDevitoRPiemonteFComparcolaDGuidiRMarcelliniM: Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. Eur J Endocrinol 155: 735– 743, 2006.
   PubMed Web of Science ®Google Scholar
• AlisiAMancoMDevitoRPiemonteFNobiliV: Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 50: 645– 649, 2010.
   PubMed Web of Science ®Google Scholar
• PacificoLCelestreMAnaniaCPaolantonioPChiesaCLaghiA MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pediatric non-alcoholic fatty liver disease. Acta Paediatr 96: 542– 547, 2007.
   PubMed Web of Science ®Google Scholar
• MancoMBedogniGMontiLMorinoGNataliGNobiliV: Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease. Atherosclerosis 209: 463– 468, 2010.
   PubMed Web of Science ®Google Scholar
• PacificoLAnaniaCMartinoFCantisaniVPasconeRMarcantonioAChiesaC: Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease. Hepatology 52: 1643– 1651, 2010.
   PubMed Web of Science ®Google Scholar
• NadeauKJKlingensmithGZeitlerP: Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J Pediatr Gastroenterol Nutr 41: 94– 98, 2005.
   PubMed Web of Science ®Google Scholar
• BedogniGGastaldelliAMancoMDe ColAAgostiFTiribelliCSartorioA: Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children. Nutr Metab Cardiovasc Dis, in press.
   Web of Science ®Google Scholar
• PerseghinGBonfantiRMagniSLattuadaGDe CobelliFCanuTEspositoAScifoPNtaliGCostantinoFBosioLRagognaFDel MaschioAChiumelloGLuziL: Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 291: E697– E703, 2006.
   PubMed Web of Science ®Google Scholar
• DeivanayagamSMohammedBSVitolaBENaguibGHKeshenTHKirkEPKleinS: Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents. Am J Clin Nutr 88: 257– 262, 2008.
   PubMed Web of Science ®Google Scholar
• CaliAMDe OliveiraAMKimHChenSReyes-MugicaMEscaleraSDziuraJTaksaliSEKursaweRShawMSavoyeMPierpontBConstableRTCaprioS: Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link? Hepatology 49: 1896– 1903, 2009.
   PubMed Web of Science ®Google Scholar
• D'AdamoECaliAMWeissRSantoroNPierpontBNorthrupVCaprioS: Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 33: 1817– 1822, 2010.
   PubMed Web of Science ®Google Scholar
• FabbriniEdeHasethDDeivanayagamSMohammedBSVitolaBEKleinS: Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content. Obesity 17: 25– 29, 2009.
   PubMed Web of Science ®Google Scholar
• WallaceTMLevyJCMatthewsDR: Use and abuse of HOMA modeling. Diabetes Care 27: 1487– 1495, 2004.
   PubMed Web of Science ®Google Scholar
• GungorNBachaFSaadRJanoskyJArslanianS: Youth type 2 diabetes: insulin resistance, beta-cell failure, or both? Diabetes Care 28: 638– 644, 2005.
   PubMed Web of Science ®Google Scholar
• StorlienLOakesNDKelleyDE: Metabolic flexibility. Proc Nutr Soc 63: 363– 368, 2004.
   PubMed Web of Science ®Google Scholar
• NobiliVMarcelliniMMarchesiniGVanniEMancoMVillaniABugianesiE: Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children. Diabetes Care 30: 2638– 2640, 2007.
   PubMed Web of Science ®Google Scholar
• LimJSMietus-SnyderMValenteASchwarzJMLustigRH: The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol 7: 251– 264, 2010.
   PubMed Web of Science ®Google Scholar
• VosMMcClainCJJonesD: Fructose is associated with increased oxidative stress and elevated plasma triglycerides in children with nonalcoholic fatty liver disease. Hepatology 48: 820A, 2008.
   Web of Science ®Google Scholar
• ShapiroHTehillaMAttal-SingerJBruckRLuzzattiRSingerP: The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease. Clin Nutr 30: 6– 19, 2011.
   PubMed Web of Science ®Google Scholar
• SimopoulosAP: Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 21: 495– 505, 2002.
   PubMed Web of Science ®Google Scholar
• NobiliVMancoM: Therapeutic strategies for pediatric non-alcoholic fatty liver disease: a challenge for health care providers. World J Gastroenterol 13: 2639– 2641, 2007.
   PubMed Web of Science ®Google Scholar
• MancoMGiordanoUTurchettaAFruhwirthRAncinelliMMarcelliniMNobiliV: Insulin resistance and exercise capacity in male children and adolescents with non-alcoholic fatty liver disease. Acta Diabetol 46: 97– 104, 2009.
   PubMed Web of Science ®Google Scholar
• NobiliVMancoMCiampaliniPAlisiADevitoRBugianesiEMarcelliniMMarchesiniG: Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Clin Ther 30: 1168– 1176, 2008.
   PubMed Web of Science ®Google Scholar
• NobiliVMancoMDevitoRDi CiommoVComparcolaDSartorelliMRPiemonteFMarcelliniMAnguloP: Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 48: 119– 128, 2008.
   PubMed Web of Science ®Google Scholar
• VajroPFranzeseAValerioGIannucciMPAragioneN: Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children. J Pediatr 136: 739– 743, 2000.
   PubMed Web of Science ®Google Scholar
• ReinehrTKleberMToschkeAM: Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence. Atherosclerosis 207: 174– 180, 2009.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health & Human Services, U.S. National Institutes of Health: Web site. Accessed at: http://www.clinicaltrials.gov/
   Google Scholar